Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
Hovedforfatter: | Karim, Samia Binte |
---|---|
Andre forfattere: | Azam, Faruque |
Format: | Thesis |
Sprog: | English |
Udgivet: |
Brac University
2024
|
Fag: | |
Online adgang: | http://hdl.handle.net/10361/23944 |
Lignende værker
-
Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
af: Hoque, Ismoth Ara
Udgivet: (2024) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
af: Paul, Pulock
Udgivet: (2024) -
Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
af: Rahman, Tasnim
Udgivet: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
af: Flora, Sanzida Alam
Udgivet: (2024) -
Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
af: Hasan, Sakib
Udgivet: (2024)